title: The course of adverse effects of nortriptyline and venlafaxine in elderly patients with major depression.
authors.affiliation: Department of Old Age Psychiatry, Parnassia Psychiatric Institute, the Hague, the Netherlands.
authors.forename: Rob M
authors.initials: RM
authors.lastname: Kok
authors.forename: Marja
authors.initials: M
authors.lastname: Aartsen
authors.forename: Willem A
authors.initials: WA
authors.lastname: Nolen
authors.forename: T
authors.initials: T
authors.lastname: Heeren
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects* / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects* / Q000627:therapeutic use; D015897:Comorbidity; D003430:Cross-Sectional Studies; D003511:Cyclohexanols / Q000009:adverse effects* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D005260:Female; D005500:Follow-Up Studies; D006778:Hospitals, Psychiatric; D006801:Humans; D008297:Male; D008875:Middle Aged; D009426:Netherlands; D009661:Nortriptyline / Q000009:adverse effects* / Q000627:therapeutic use; D010552:Personality Assessment; D012307:Risk Factors; D000069470:Venlafaxine Hydrochloride
chemical_list: D018687:Antidepressive Agents, Second-Generation; D000929:Antidepressive Agents, Tricyclic; D003511:Cyclohexanols; D000069470:Venlafaxine Hydrochloride; D009661:Nortriptyline